Literature DB >> 12147699

Inhibition of translation by UAUUUAU and UAUUUUUAU motifs of the AU-rich RNA instability element in the HPV-1 late 3' untranslated region.

Lisa Wiklund1, Marcus Sokolowski, Anette Carlsson, Margaret Rush, Stefan Schwartz.   

Abstract

The human papillomavirus type 1 (HPV-1) late mRNAs contain a 57-nucleotide adenosine- and uridine-rich RNA instability element termed h1ARE in their late 3' untranslated regions. Here we show that five sequence motifs in the h1ARE (named I-V) affect the mRNA half-life in an additive manner. The minimal inhibitory sequence in motifs I and II was mapped to UAUUUAU, and the minimal inhibitory sequence in motifs III-V was mapped to UAUUUUUAU. We also provide evidence that the same motifs in the AU-RNA instability element inhibit mRNA translation, an effect that was entirely dependent on the presence of a poly(A) tail on the mRNA. Additional experiments demonstrated that the h1ARE interacted directly with the poly(A)-binding protein, suggesting that the h1ARE inhibits translation by interfering with the function of the poly(A)-binding protein.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12147699     DOI: 10.1074/jbc.M205929200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Mutational inactivation of two distinct negative RNA elements in the human papillomavirus type 16 L2 coding region induces production of high levels of L2 in human cells.

Authors:  Daniel Oberg; Brian Collier; Xiaomin Zhao; Stefan Schwartz
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

2.  Gene codon composition determines differentiation-dependent expression of a viral capsid gene in keratinocytes in vitro and in vivo.

Authors:  Kong-Nan Zhao; WenYi Gu; Ning Xia Fang; Nicholas A Saunders; Ian H Frazer
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

3.  A downstream polyadenylation element in human papillomavirus type 16 L2 encodes multiple GGG motifs and interacts with hnRNP H.

Authors:  Daniel Oberg; Joanna Fay; Helen Lambkin; Stefan Schwartz
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Serine- and arginine-rich proteins 55 and 75 (SRp55 and SRp75) induce production of HIV-1 vpr mRNA by inhibiting the 5'-splice site of exon 3.

Authors:  Anna Tranell; Eva Maria Fenyö; Stefan Schwartz
Journal:  J Biol Chem       Date:  2010-08-04       Impact factor: 5.157

5.  A majority of the cancer/testis antigens are intrinsically disordered proteins.

Authors:  Krithika Rajagopalan; Steven M Mooney; Nehal Parekh; Robert H Getzenberg; Prakash Kulkarni
Journal:  J Cell Biochem       Date:  2011-11       Impact factor: 4.429

6.  A 57-nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2, and polypyrimidine tract binding protein.

Authors:  Xiaomin Zhao; Daniel Oberg; Margaret Rush; Joanna Fay; Helen Lambkin; Stefan Schwartz
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

7.  Tristetraprolin Recruits Eukaryotic Initiation Factor 4E2 To Repress Translation of AU-Rich Element-Containing mRNAs.

Authors:  Xianzun Tao; Guangxia Gao
Journal:  Mol Cell Biol       Date:  2015-09-14       Impact factor: 4.272

Review 8.  Regulation of human papillomavirus gene expression by splicing and polyadenylation.

Authors:  Cecilia Johansson; Stefan Schwartz
Journal:  Nat Rev Microbiol       Date:  2013-03-11       Impact factor: 60.633

9.  Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene.

Authors:  Xiaomin Zhao; Margaret Rush; Stefan Schwartz
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  Polypyrimidine tract binding protein induces human papillomavirus type 16 late gene expression by interfering with splicing inhibitory elements at the major late 5' splice site, SD3632.

Authors:  Monika Somberg; Xiaomin Zhao; Monika Fröhlich; Magnus Evander; Stefan Schwartz
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.